Tags: RSV vaccination,Older adults,Pharmacists,Vaccine hesitancy,Respiratory syncytial virus,Community outreach,Clinical impact,Vaccine safety,Vaccine efficacy,Pharmacy practice,Health literacy,Patient counseling,Medication therapy management,High-risk populations,Immunization strategies,Vaccine education,Infection prevention,Hospitalization rates,RSV awareness,ConquerRSV,AReSVi-006,RENOIR study,Pharmacist-led initiatives,Patient care,Health recommendations,Seasonal infections,Pharmacy workflows,Older adult health,Viral transmission,Chronic conditionsRSV,respiratory syncytial virus,RSV transmission,transmission,incidence,RSV incidence,high risk,hospitalization risk,symptoms,RSV symptoms,severe RSV,mild RSVRSV vaccine,respiratory syncytial virus immunization,RSV prevention,RSV vaccine efficacy,RSV vaccine safety,RSV vaccine clinical trials,infants,elderly,adverse events,RSV vaccine schedule,vaccine dosage,vaccine availability,vaccine cost,vaccine research,vaccine development,vaccine approval,RSV vaccine for pregnant women,RSV vaccine immunity,RSV vaccine administrationrespiratory syncytial virus,RSV,RSV transmission,limiting transmission,limiting RSV transmission,transmission prevention,preventing RSV,preventing RSV transmission,RSV prevention,RSV vaccine,RSV vaccinationrespiratory syncytial virus,RSV,adjuvanted vaccine,nonadjuvanted vaccine,RSV vaccine preparation,preparation,dosing,vaccine administration,RSV vaccine,RSV vaccination,RSV vaccine dosing,RSV vaccine administration
Journalists covering RSV
MedPage Today, Pharmacy Times, STAT News, Live Science and others - 41 journalists.